Savient Pharmaceuticals Inc (NASDAQOTH:SVNTQ)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar truthiac (< 20) Submitted: 11/4/2008 7:54:03 PM : Outperform Start Price: $5.17 SVNTQ Score: -192.60

After a major gap down on false rumors, the gap is likely to fill in the coming months, especially in view of the expected positive news flow in December-January.

Featured Broker Partners


Advertisement